Cancer BiologybioRxiv
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting
D. Viola, A. Dona, E. Caserta…·F. Pichiorri
This study shows that daratumumab targets CD38+ NK cells to induce immune activation and anti-myeloma activity despite reducing total NK cell frequency.
DOI 10.1038/s41375-020-0810-4